1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On April 15, 2026, Bloomia Holdings' borrowers made a $4,900,000 initial payment toward a discounted prepayment of their bridge loan under a Second Amendment. Any unpaid portion accrues 12% interest and must be paid by May 27, 2026, or the bridge loan balance will be reduced based on the unpaid share. The company also borrowed $1,000,000 from Gary Kohler under an unsecured note at a fixed 11.5% rate, which it used to fund the payment.
Initial payment of $4,900,000 made April 15, 2026, against a $7,330,000 discounted prepayment amount; the minimum required was $4,800,000.
Unpaid discounted prepayment balance accrues 12% interest from April 16, 2026, with full payment due by May 27, 2026.
If the balance is not paid by May 27, 2026, the $15,097,053 bridge loan balance is reduced in proportion to the unpaid amount.
Unsecured $1,000,000 promissory note from Gary Kohler dated April 1, 2026, bears 11.5% interest and matures March 31, 2029.
Trevi Therapeutics agreed to sell 11.6 million new common shares at $13.00 each, for about $150 million before fees, with the Company estimating net proceeds of about $141.1 million. The Company said it had about $171.8 million in cash and securities as of March 31, 2026, and that this cash plus the offering proceeds will fund operations through 2029, while the sale also adds new shares outstanding for existing holders.
Offering of 11.6 million shares at $13.00 per share, with underwriters at $12.22 per share; closing expected on or about April 20, 2026.
Estimated net proceeds of about $141.1 million, or about $162.4 million if the 1,740,000-share underwriter option is exercised in full.
Cash, cash equivalents and marketable securities of about $171.8 million as of March 31, 2026, preliminary and unreviewed by the auditor.
Company expects cash to fund operations through 2029; first Phase 3 trial topline results expected in the first half of 2028.
Fifth Third reported first-quarter 2026 net income available to common shareholders of $128 million, or $0.15 per diluted share, down from $699 million ($1.04) in the prior quarter and $478 million ($0.71) a year earlier. The results include two months of Comerica, which the company acquired on February 1, 2026, and merger-related charges that reduced diluted EPS by $0.68, so revenue growth did not carry through to profit.
Net interest income rose 34% year over year to $1.939 billion, and noninterest income rose 29% to $895 million.
Noninterest expense was $2.395 billion, including $635 million of pre-tax merger-related charges; after-tax merger-related charges were $510 million.
Comerica acquisition closed February 1, 2026, in an all-stock deal valued at approximately $12.7 billion; the CET1 capital ratio fell to 9.96% from 10.81% in the prior quarter.
No share repurchases occurred in the first quarter of 2026.
Autoliv reported first-quarter 2026 net sales of $2,753 million, up 6.8%, with 0.8% organic growth, while diluted EPS fell 12% to $1.88 on lower operating income and higher financial and non-operating costs. Operating cash flow was negative $76 million, driven by working capital. The company reiterated its full-year 2026 guidance, so shareholders get a mixed quarter with no change to the outlook.
Net sales were $2,753 million, up 6.8%; organic sales growth was 0.8% against a global light vehicle production decline of 3.4%.
Diluted EPS was $1.88, down 12%; adjusted diluted EPS was $2.05, down 4.7%.
Operating cash flow was negative $76 million and free operating cash flow was negative $159 million.
Full-year 2026 guidance was reiterated: organic sales growth around 0%, adjusted operating margin around 10.5-11%, and operating cash flow around $1.2 billion.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.